NEW YORK, July 03, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Jumia Technologies AG (NYSE: JMIA)
Class Period: Purchasers of American Depositary Shares between April 12, 2019 and May 9, 2019
Lead Plaintiff Deadline: July 15, 2019
The lawsuit alleges that throughout the class period, Jumia Technologies AG made materially false and/or misleading statements and/or failed to disclose that: (a) Jumia had materially overstated its active customers and active merchants; (b) Jumia’s representations about its orders, order cancellations, undelivered orders and returned orders lacked a sufficient factual basis and materially overstated the Company’s sales; (c) Jumia failed to sufficiently disclose related party transactions; and (d) Jumia’s financial statements were presented in violation of applicable accounting standards.
Get additional information about the JMIA lawsuit: http://www.kleinstocklaw.com/pslra-1/jumia-technologies-ag-loss-submission-form?wire=3
Equity Bancshares, Inc. (NASDAQ: EQBK)
Class Period: May 11, 2018 to April 22, 2019
Lead Plaintiff Deadline: July 12, 2019
During the class period, Equity Bancshares, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate internal controls to assess credit risk; (2) as a result, certain of the Company’s loans posed an increased risk of loss; (3) as a result, the Company was reasonably likely to incur significant losses for certain substandard loans; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Get additional information about the EQBK lawsuit: http://www.kleinstocklaw.com/pslra-1/equity-bancshares-inc-loss-submission-form?wire=3
Hecla Mining Company (NYSE: HL)
Class Period: March 19, 2018 to May 8, 2019
Lead Plaintiff Deadline: July 23, 2019
The complaint alleges that throughout the class period Hecla Mining Company made materially false and/or misleading statements and/or failed to disclose that: (a) the Nevada operations were hemorrhaging cash due to a multitude of material problems identified by Defendants during Hecla’s extensive due diligence of the Nevada mines before the Class Period, and (b) as a result of these material problems, Defendants had no reasonable basis for their representations that the Nevada operations would be in a position to have positive or self-funding cash flow.
Get additional information about the HL lawsuit: http://www.kleinstocklaw.com/pslra-1/hecla-mining-company-loss-submission-form?wire=3
Diebold Nixdorf, Incorporated (NYSE: DBD)
Class Period: May 4, 2017 to July 4, 2017
Lead Plaintiff Deadline: September 3, 2019
The complaint alleges Diebold Nixdorf, Incorporated made materially false and/or misleading statements and/or failed to disclose that: (i) the Company was experiencing delays in systems rollouts as well as a longer customer decision making process and order-to-revenue conversion cycle; (ii) the foregoing issues were negatively impacting the Company’s services business and operations; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Get additional information about the DBD lawsuit: http://www.kleinstocklaw.com/pslra-1/diebold-nixdorf-incorporated-loss-submission-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.